BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2
11 results:

  • 1. Predictive Role of a Novel Ferroptosis-Related lncRNA Pairs Model in the Prognosis of Papillary Thyroid Carcinoma.
    Xiao W; Lai Y; Yang H; Que H
    Biochem Genet; 2024 Apr; 62(2):775-797. PubMed ID: 37436560
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
    Pretta A; Ziranu P; Giampieri R; Donisi C; Cimbro E; Spanu D; Lai E; Pecci F; Balconi F; Lupi A; Pozzari M; Persano M; Murgia S; Pusceddu V; Puzzoni M; Berardi R; Scartozzi M
    Dig Liver Dis; 2023 May; 55(5):655-660. PubMed ID: 36513569
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cystic pancreatic neuroendocrine tumors: a multidisciplinary diagnostic challenge.
    Bazaga S; Morales-Alvarado J; Bas-Cutrina F; Fernandez Monclús E; Méndez Coca I
    Rev Esp Enferm Dig; 2022 Nov; 114(11):691-692. PubMed ID: 35607931
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Deng J; Zhang J; Ye Y; Liu K; Zeng L; Huang J; Pan L; Li M; Bai R; Zhuang L; Huang X; Wu G; Wei L; Zheng Y; Su J; Zhang S; Chen R; Lin D; Zheng J
    Cancer Res; 2021 Oct; 81(20):5268-5283. PubMed ID: 34362795
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.
    Pretta A; Ziranu P; Puzzoni M; Lai E; Orsi G; Liscia N; Molinaro E; Mariani S; Riggi L; Rovesti G; Dubois M; Migliari M; Persano M; Saba G; Impera V; Musio F; Batzella E; Demurtas L; Pusceddu V; Astara G; Faloppi L; Casadei Gardini A; Andrikou K; Cascinu S; Scartozzi M
    Tumori; 2021 Dec; 107(6):550-555. PubMed ID: 33243068
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?
    Karp I; Sivaswamy A; Booth C
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):489-499. PubMed ID: 30779266
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prevalence of cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
    Jalil NA; Zin AA; Othman NH
    Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.
    Walker EJ; Ko AH; Holly EA; Bracci PM
    Int J Cancer; 2015 Mar; 136(6):E646-53. PubMed ID: 25091126
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Type 2 diabetes mellitus and pancreatic cancer.
    McAuliffe JC; Christein JD
    Surg Clin North Am; 2013 Jun; 93(3):619-27. PubMed ID: 23632148
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incidence of pancreatic cancer in Greenland 2000-2010.
    Kirkegaard J
    Int J Circumpolar Health; 2012 May; 71():18368. PubMed ID: 22663941
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus.
    Krechler T; Zeman M; Vecka M; Macasek J; Jachymova M; Zima T; Zak A
    Neoplasma; 2011; 58(1):58-64. PubMed ID: 21067267
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.